Current potential and limitations of molecular diagnostic methods in head and neck cancer

被引:15
|
作者
Mahfouz, Magdy E. [2 ]
Rodrigo, Juan P. [3 ]
Takes, Robert P. [4 ]
Elsheikh, Mohamed N. [5 ]
Rinaldo, Alessandra [1 ]
Brakenhoff, Ruud H. [6 ]
Ferlito, Alfio [1 ]
机构
[1] Univ Udine, Dept Surg Sci, ENT Clin, Policlin Univ, I-33100 Udine, Italy
[2] Kafrelsheikh Univ, Dept Zool, Kafrelsheikh, Egypt
[3] Inst Univ Oncol Principado Asturias, Dept Otolaryngol, Hosp Univ Cent Asturias, Oviedo, Spain
[4] Radboud Univ Nijmegen, Dept Otolaryngol Head & Neck Surg, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[5] Tanta Univ, Dept Otolaryngol Head & Neck Surg, Tanta, Egypt
[6] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
Molecular diagnostic techniques; Molecular markers; Lymph node metastasis; Head and neck cancer; Prognosis; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE MICROMETASTASES; IMMUNOHISTOCHEMICAL DETECTION; MICROSATELLITE ALTERATIONS; MICROARRAY DATA; POOR-PROGNOSIS; GENE; METASTASIS; IDENTIFICATION; MARKERS;
D O I
10.1007/s00405-009-1177-3
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Traditional diagnostic methods such as clinical assessment, histopathological examination and imaging techniques are limited in their capacity to provide information on prognosis and treatment choice of head and neck cancer. In recent years, molecular techniques have been developed that enabled us to get more insight into the molecular biological cellular pathways underlying tumor progression and metastasis. Correlation of these molecular changes with clinical events has been explored. However, consistently useful markers have not been identified yet, although many promising developments are in progress. It may be expected that in the near future, molecular markers will be useful for clinical purposes. In this paper, an overview will be given of the several molecular techniques that may have potential to be introduced in clinical practice in the management of head and neck squamous cell carcinoma.
引用
收藏
页码:851 / 860
页数:10
相关论文
共 50 条
  • [41] Potentials and limitations of molecular diagnostic methods in food safety
    Lauri, Andrea
    Mariani, Paola O.
    GENES AND NUTRITION, 2009, 4 (01): : 1 - 12
  • [42] Possibilities and limitations of palliative surgery in head and neck cancer patients
    Weber, F.
    Schuss, U.
    Sittel, C.
    HNO, 2020, 68 (07) : 498 - 502
  • [43] Current status of biomarkers in head and neck cancer
    Chang, Steven S.
    Califano, Joseph
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (08) : 640 - 643
  • [44] Current Concepts in Chemotherapy for Head and Neck Cancer
    Sindhu, Simran K.
    Bauman, Julie E.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2019, 31 (01) : 145 - +
  • [45] Current Role of Dacomitinib in Head and Neck Cancer
    Elicin, Olgun
    Ozsahin, Mahmut
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (06) : 735 - 742
  • [46] Current Challenges in Head and Neck Cancer Management
    Starzynska, Anna
    Sobocki, Bartosz Kamil
    Alterio, Daniela
    CANCERS, 2022, 14 (02)
  • [47] Current relevance of hypoxia in head and neck cancer
    Bredell, Marius G.
    Ernst, Jutta
    El-Kochairi, Ilhem
    Dahlem, Yuliya
    Ikenberg, Kristian
    Schumann, Desiree M.
    ONCOTARGET, 2016, 7 (31) : 50781 - 50804
  • [48] Current status of IMRT in head and neck cancer
    Gomez-Millan, Jaime
    Romero Fernandez, Jesus
    Medina Carmona, Jose Antonio
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (06) : 371 - 375
  • [49] Current studies of immunotherapy in head and neck cancer
    Dogan, V.
    Rieckmann, T.
    Muenscher, A.
    Busch, C. -J.
    CLINICAL OTOLARYNGOLOGY, 2018, 43 (01) : 13 - 21
  • [50] CURRENT CHEMOTHERAPY OF HEAD AND NECK-CANCER
    AMREIN, P
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1991, 49 (08) : 864 - 870